Cover Image

Transcriptome-wide N6-methyladenosine modification profiling of long non-coding RNAs in patients with recurrent implantation failure

Abstract N 6-methyladenosine (m6A) is involved in most biological processes and actively participates in the regulation of reproduction. According to recent research, long non-coding RNAs (lncRNAs) and their m6A modifications are involved in reproductive diseases. In the present study, using m6A-mod...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ting Wang (Author), Lili Zhang (Author), Wenxin Gao (Author), Yidan Liu (Author), Feng Yue (Author), Xiaoling Ma (Author), Lin Liu (Author)
Format:	Book
Published:	BMC, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis
by: Lei Wan, et al.
Published: (2022)

Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer
by: Xin Huang, et al.
Published: (2022)

The role of N-methyladenosine modification in acute and chronic kidney diseases
by: Saiqi Qi, et al.
Published: (2023)

Functions of RNA N6-methyladenosine modification in acute myeloid leukemia
by: Xue Zheng, et al.
Published: (2021)

Novel insights into the interaction between N6-methyladenosine modification and circular RNA
by: Tao Xu, et al.
Published: (2022)

Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
by: Jiali Yao, et al.
Published: (2023)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
by: Chen Gao, et al.
Published: (2022)

SINEUP non-coding RNA activity depends on specific N6-methyladenosine nucleotides
by: Bianca Pierattini, et al.
Published: (2023)

Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
by: Vilbert Sikorski, et al.
Published: (2022)

N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
by: Yi Niu, et al.
Published: (2018)

Prognostic analysis of patients with gastric cancer based on N6-methyladenosine modification patterns and tumor microenvironment characterization
by: Miaomiao Huo, et al.
Published: (2024)

The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression
by: Wenhao Zhu, et al.
Published: (2023)

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases
by: Yan Teng, et al.
Published: (2023)

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17
by: Junting Zhang, et al.
Published: (2023)

N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
by: Sihan Zhou, et al.
Published: (2023)

Transcriptome-Wide 5-Methylcytosine Profiling of lncRNAs in the Mouse Cerebral Ischemia Model
by: Chao Zhang, et al.
Published: (2024)

N6-methyladenine modification in noncoding RNAs and its function in cancer
by: Xinyu Yang, et al.
Published: (2020)

The role of RNA N6-methyladenosine methyltransferase in cancers
by: Jiali Huang, et al.
Published: (2021)

The crosstalk between N6‐methyladenosine readers and neuroblastoma
by: Liping Chen, et al.
Published: (2024)

RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023)

Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
by: Jiayi He, et al.
Published: (2023)

Parallel Genome-wide Profiling of Coding and Non-coding RNAs to Identify Novel Regulatory Elements in Embryonic and Maturated Heart
by: Davood Sabour, et al.
Published: (2018)

Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia
by: Wei-Wei Liu, et al.
Published: (2022)

Genome-wide identification of cell type-specific susceptibility genes for Juvenile dermatomyositis through the analysis of N6-methyladenosine-associated SNPs
by: Huan Zhang, et al.
Published: (2024)

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
by: Wenli Cheng, et al.
Published: (2022)

Promotion of the resistance of human oral epithelial cells to herpes simplex virus type I infection via N6-methyladenosine modification
by: Junping Xu, et al.
Published: (2023)

Dual effects of N6-methyladenosine on cancer progression and immunotherapy
by: Hui Li, et al.
Published: (2021)

The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
by: Zhaolin Chen, et al.
Published: (2022)

Non-Coding RNAs Regulate Placental Trophoblast Function and Participate in Recurrent Abortion
by: Xin Chen, et al.
Published: (2021)

N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway
by: Yuan-Xue Jing, et al.
Published: (2023)

The emerging roles of N6-methyladenosine RNA methylation in human cancers
by: Huafei Shen, et al.
Published: (2020)

Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis
by: Haijiao Long, et al.
Published: (2024)

The emerging role of RNA N6-methyladenosine methylation in breast cancer
by: Fangchao Zheng, et al.
Published: (2021)

YTHDF3 promotes melanoma metastasis by reading N6‐methyladenosine
by: Ivan Yu Cheng, et al.
Published: (2022)

Non-Coding RNAs
Published: (2020)

N6-Methyladenosine METTL3 Modulates the Proliferation and Apoptosis of Lens Epithelial Cells in Diabetic Cataract
by: Jun Yang, et al.
Published: (2020)

In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases
by: Naoko Suga, et al.
Published: (2023)

Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis
by: Tong X, et al.
Published: (2023)

N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas
by: Feng Yuan, et al.
Published: (2022)

Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL
by: Kai-Jian Chu, et al.
Published: (2020)